Note: The transactions reported here refer to legal insider trading — purchases, sales, and other dealings in company securities by executives, directors, and major shareholders, which are required by law to be disclosed to the SEC via Form 4 filings within two business days of the transaction. This article covers the top 100 most significant transactions by dollar value from today's filings. This is entirely distinct from illegal insider trading, which involves buying or selling securities based on material, non-public information in violation of US federal securities law and equivalent legislation in other jurisdictions.
Insider trading activity on October 8, 2026, leaned heavily bearish, with sales overwhelmingly outnumbering purchases by a ratio of nearly 7-to-1. While a handful of notable buys emerged—primarily concentrated in a few high-profile stocks—the broader trend showed significant selling pressure, particularly in the healthcare and technology sectors. The day's transactions totaled 100, with only 13 purchases compared to 87 sales, signaling cautious or profit-taking behavior among corporate insiders.
The largest insider buys were dominated by Berkshire Hathaway-related activity. Lennar Corporation saw two massive purchases totaling $271.4 million by Berkshire Hathaway Inc., its 10% owner, while Kodiak Sciences Inc. attracted a $60.5 million investment from Baker Bros. Advisors LP, a director of the company. Berkshire Hathaway itself also saw insider buying, with $52.4 million invested in both its Class A (BRK-A) and Class B (BRK-B) shares by its own 10% owner. These moves suggest strong confidence in these holdings by one of the market's most closely watched investors.
On the sell side, Eli Lilly and Company led with a proposed sale of $347.2 million by shareholder Lilly Endowment, Inc. Elastic N.V. dominated the rest of the top sales, with four major transactions totaling $552.2 million. Two proposed sales of $140.9 million each came from director CMXI B.V., while director Steven Schuurman executed two actual sales of $135.2 million apiece. The heavy selling in Elastic N.V. may indicate internal expectations of a valuation reset or strategic portfolio adjustments by key stakeholders.
Today’s data reflects a cautious market environment where insiders appear to be locking in gains, particularly in high-growth and healthcare names, while a few high-conviction buys stand out in real estate and insurance-related stocks. The disparity between buys and sales suggests that corporate insiders may be anticipating near-term headwinds or simply capitalizing on recent gains.
Related Reading
Regulatory Developments→Market News→Bulls & Bears Outlook→Track all insider trades in real time on the MarketsFN Insider Trading Tracker.
Top 10 Stocks — Insider Activity
Price Charts — Top 3 Stocks
LLY — Eli Lilly and Company
ESTC — Elastic N.V.
ESTC — Elastic N.V.
MarketsFN Insider Trading Tracker
Monitor all SEC Form 4 filings in real time — filter by company, role, transaction type and dollar value.
Source: SEC Form 4 filings. Updated twice daily.
